APOSAN Dr. Künzer GmbH
APOSAN is a German compounding pharmacy and ambulatory home-therapy provider producing patient-individual sterile infusion solutions, parenteral nutrition, and elastomer pump services for chronic and post-acute patients across Germany, reimbursed via statutory and private health insurers.
- Company typePrivate
- Founded1991
- HeadquartersKöln, Germany
- Headcount—
- GTM typeB2C
- OfferingServices
What APOSAN Dr. Künzer GmbH does
APOSAN Dr. Künzer GmbH (legal name APOSAN GmbH) is a Cologne-based, privately held German compounding pharmacy and ambulatory home-therapy provider, founded around 1991 and operating as the German subsidiary of the international healthcare group Santé Cie Deutschland GmbH. The company employs approximately 200 staff of multiple nationalities and serves patients across all of Germany. APOSAN produces patient-individual sterile infusion solutions and parenteral nutrition bags in GMP-compliant cleanroom conditions, and distributes battery-free elastomer pumps for ambulatory drug administration. Its portfolio spans at least eight complex therapy areas, including ambulatory parenteral antibiotic therapy (APAT), parenteral and enteral nutrition, intravitreal VEGF antagonist injection therapy (IVOM) for age-related macular degeneration, cystic fibrosis care, short bowel syndrome support, iron chelation for hemochromatosis, and post-lung transplant medication management.
The business operates a referral-driven go-to-market model in which prescribing physicians and hospital departments initiate therapy, and APOSAN handles compounding production, prescription and reimbursement management, nationwide field-care nurse visits, patient training, and direct home delivery. Revenue is generated per prescription and reimbursed through German statutory (GKV) and private (PKV) health insurers, with supplementary revenue from medical device distribution (elastomer pumps and enteral nutrition equipment), standard product sales through the affiliated APOSAN Versandapotheke shipping pharmacy, and care-coordination services. APOSAN reaches patients and clinicians through its website, WhatsApp-based support, LinkedIn and Xing presence, YouTube educational content, professional webinars with academic medical centers such as UKSH Lübeck, and direct engagement with physician and hospital referral networks.
APOSAN Dr. Künzer GmbH firmographics
Firmographics- Name
- APOSAN Dr. Künzer GmbH
- Legal name
- APOSAN GmbH
- Website
- https://aposan.de
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Short description
- APOSAN is a German compounding pharmacy and ambulatory home-therapy provider producing patient-individual sterile infusion solutions, parenteral nutrition, and elastomer pump services for chronic and post-acute patients across Germany, reimbursed via statutory and private health insurers.
- Ownership category
- akta.pro rank
APOSAN Dr. Künzer GmbH industry classification
Industry- Product category
- Compounding Pharmacy / Home Infusion Services
- NAICS
- Home Health Care Services (62161), Pharmacies and Drug Retailers (45611), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Services-Home Health Care Services (8082), Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Infusion & Home Infusion Pharmacy Services (HLAFALAG)
- akta.pro secondary industries
- Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE), In-Home Infusion Pharmacy Support & Coordination (HSABALAH)
Keywords
Where APOSAN Dr. Künzer GmbH is headquartered
LocationHeadquarters
- HQ city
- Köln
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
APOSAN Dr. Künzer GmbH business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Compounding Pharmacy - Patient-Individual Medications: APOSAN manufactures and supplies patient-specific compounded sterile medications (antibiotic infusions, parenteral nutrition) billed to public health insurers (GKV/PKV) under Germany's healthcare reimbursement framework. Individual prescriptions from physicians generate revenue per preparation/administration cycle.
- Medical Supplies and Devices: Supply of medical devices including elastomer pumps and enteral nutrition equipment, provided alongside compounding medications. Revenue generated through healthcare insurance reimbursement and direct supply arrangements.
- Shipping Pharmacy - Standard Products: APOSAN's affiliated shipping pharmacies (APOSAN Versandapotheke) supply manufacturer-neutral standard pre-made infusion bags and standard medical supplies, billed through standard pharmacy reimbursement channels.
- Care Coordination and Transfer Management Services: Transition management services supporting patients moving from hospital to home care, including discharge coordination, prescription management, and insurance billing administration as part of the comprehensive care package.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
APOSAN Dr. Künzer GmbH product offering
Product offeringCore offering
APOSAN is a German compounding pharmacy that produces patient-individual sterile infusion solutions and parenteral nutrition bags in aseptic cleanroom environments. The company dispenses these compounded preparations together with elastomer pumps directly to patients' homes nationwide, and provides integrated care coordination, patient training, and prescription/reimbursement management for ambulatory drug therapy in chronic conditions.
Product overview
APOSAN is a pharmaceutical healthcare company specializing in outpatient (ambulant) drug therapies for complex medical conditions. The company produces patient-individual sterile infusion solutions (Compounding Beutel) manufactured in clean rooms and delivers them along with elastomer pumps to patients' homes. APOSAN's portfolio includes multiple therapy services for conditions including antibiotic therapy (APAT), parenteral/enteral nutrition, age-related macular degeneration (IVOM), cystic fibrosis, short bowel syndrome, hemochromatosis, and post-lung transplant care. These services are supported by a nationwide team of patient care coordinators and include prescription management, package tracking, and comprehensive patient training for self-administration at home.
Differentiator
Problem solved
Functional benefit
Products and services
- Ambulante parenterale Antibiotikatherapie (APAT) Home-based outpatient intravenous antibiotic therapy service that allows patients to receive intravenous antibiotic treatments in their own homes using elastomer pumps, avoiding or shortening hospital stays.
- Parenterale Ernährung (Parenteral Nutrition) Individually compounded parenteral nutrition solutions (all-in-one bags) for patients who cannot obtain sufficient nutrition orally or enterally, produced in APOSAN's cleanrooms per physician and nutritionist specifications.
- Enterale Ernährung (Enteral Nutrition) Tube feeding solutions and related support for patients requiring nutritional support through the gastrointestinal tract, including devices and care coordination.
- AMD Therapie (Intravitreale operative Medikamenteneingabe, IVOM) Therapy support for wet age-related macular degeneration involving intravitreal injections of VEGF antagonists, including medication supply and ambulatory care coordination.
- Mukoviszidose Versorgung (Cystic Fibrosis Care) Comprehensive home care program for cystic fibrosis patients requiring specialized antibiotic infusion and nutrition support, integrated into APOSAN's home therapy model.
- Kurzdarmsyndrom Versorgung (Short Bowel Syndrome Care) Specialized nutritional and therapeutic support program for patients with short bowel syndrome who cannot maintain adequate nutrition through normal intake.
- Eisenspeicherkrankheit (Hämochromatose) Therapie Chelation therapy service for patients with iron storage disease (hemochromatosis), using deferoxamine administered subcutaneously or via elastomer pump.
- Therapie nach Lungentransplantation Post-transplant medication therapy support and ongoing monitoring service for lung transplant patients, including home IV immunosuppressive and anti-infective therapy.
- Compounding Beutel (Patient-Individual Sterile Infusion Solutions) Patient-individual sterile infusion solutions compounded in aseptic cleanroom conditions, prepared according to each physician and nutritionist's prescription to meet specific patient needs (antibiotic infusions, parenteral nutrition, specialty therapies).
- Elastomerpumpen (Elastomer Pumps) Battery-free elastomeric (elastomer) pumps supplied alongside compounded medications to enable ambulatory administration of sterile drugs and nutrients without need for electronic infusion devices.
- Patientenbetreuung und Versorgungskoordination (Nationwide Patient Care and Care Coordination) Nationwide team of qualified nursing and care coordination staff providing patient education, prescription management, insurance/billing handling, and ongoing support throughout home-based therapy.
- APOSAN Versandapotheke (Shipping Pharmacy) Affiliated online shipping pharmacy supplying manufacturer-neutral standard pre-made infusion bags and medical supplies to patients in Germany via e-prescription upload and online shipment tracking.
Quantifiable outcome
- Home infusion therapy significantly improves quality of life for patients with chronic diseases
- +1 more outcomes
Companies that use APOSAN Dr. Künzer GmbH
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
APOSAN Dr. Künzer GmbH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
APOSAN Dr. Künzer GmbH partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Santé Cie Deutschland GmbHcoreAPOSAN GmbH is a wholly-owned subsidiary (daughter company) of Santé Cie Deutschland GmbH, part of the Santé Cie international healthcare group. Santé Cie is a healthcare company focused on ambulatory care and home therapy services. APOSAN represents the German subsidiary of the Santé Cie group.
- Mukoviszidose e.V.coreAPOSAN collaborates with Mukoviszidose e.V. (German Cystic Fibrosis Association), the national patient organization for cystic fibrosis patients. This partnership is shown through APOSAN's sponsorship of the organization's logo on its website and alignment in patient support activities for CF patients who require long-term home antibiotic and nutritional therapies.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
APOSAN Dr. Künzer GmbH competitors and assessment
Company assessmentEmerging players
- EVER Pharma: EVER Pharma is a European specialty pharmaceutical company focused on injectable, infusion, and neurological products including sterile preparations. It is comparable as a smaller, growing European player in the sterile injectable and home infusion supply chain adjacent to APOSAN.
- Hameln Pharma GmbH: Hameln Pharma is a German-based specialty manufacturer of sterile injectable generics and infusion solutions, with a focus on hospital and home care channels. It competes with APOSAN in the upstream supply of sterile injectable products used in home infusion and parenteral nutrition.
- Sedana Medical AB: Sedana Medical develops and commercializes volatile anesthetic agents and devices for inhaled sedation, with growing overlap into home-based drug delivery. It is a smaller, faster-growing player compared to APOSAN but operates in adjacent home infusion and specialty pharma delivery markets in Europe.
Direct peers
- Baxter International: Baxter manufactures parenteral nutrition products, IV solutions, and ambulatory infusion pumps globally, and operates specialty pharmacy/home infusion services in selected markets. Its clinical nutrition and drug delivery portfolio directly parallels APOSAN's compounding and home infusion capabilities.
- Fresenius Kabi: Fresenius Kabi is a global leader in clinical nutrition, infusion therapy, and sterile injectable manufacturing. Its homecare arm (including the Calea brand) provides home parenteral nutrition and home infusion services in multiple European markets, making it one of the closest direct comparables to APOSAN.
- B. Braun Melsungen AG: B. Braun is a global medical and pharmaceutical company with a dedicated home care division that supplies infusion solutions, parenteral nutrition, elastomer pumps, and clinical services to home-based patients in Germany and internationally — directly overlapping APOSAN's core compounding and home infusion offering.
Broad incumbents
- CSL Behring: CSL Behring is a global biotherapeutics leader that supplies plasma-derived and specialty therapies often administered via home infusion for chronic conditions. While it operates as a manufacturer rather than a compounding pharmacy, it serves overlapping patient populations and prescribers.
Regional players
- Healthcare at Home (UK): Healthcare at Home is a major UK provider of home-based clinical services including IV therapy, parenteral nutrition, and complex chronic disease management. Comparable business model to APOSAN's hospital-to-home care pathway but operating in a different (UK) geography.
- Shop Apotheke Europe NV: Shop Apotheke is a major online pharmacy in Germany and continental Europe, offering prescription and OTC medication home delivery. Like DocMorris, it overlaps with APOSAN's shipping pharmacy arm but does not perform sterile compounding or home infusion services.
- DocMorris (Zur Rose Group): DocMorris operates one of Europe's largest online pharmacies and mail-order pharmacy platforms, including e-prescription fulfillment. While not a compounding specialist, it competes in the broader German pharmacy and home delivery of medications space alongside APOSAN's Versandapotheke channel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
APOSAN Dr. Künzer GmbH social profiles
Digital presenceAPOSAN Dr. Künzer GmbH compliance and trust
Trust signalCompliance1 record
APOSAN Dr. Künzer GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
APOSAN Dr. Künzer GmbH leadership team
Management profileNumber of profiles
Profiles2 records
APOSAN Dr. Künzer GmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
APOSAN Dr. Künzer GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about APOSAN Dr. Künzer GmbH
What does APOSAN Dr. Künzer GmbH do?
APOSAN is a German compounding pharmacy that produces patient-individual sterile infusion solutions and parenteral nutrition bags in aseptic cleanroom environments. The company dispenses these compounded preparations together with elastomer pumps directly to patients' homes nationwide, and provides integrated care coordination, patient training, and prescription/reimbursement management for ambulatory drug therapy in chronic conditions.
Is APOSAN Dr. Künzer GmbH a public or private company?
APOSAN Dr. Künzer GmbH is a private company. It is classified as corporate owned and is currently operating.
When was APOSAN Dr. Künzer GmbH founded?
APOSAN Dr. Künzer GmbH was founded in 1991.
Where is APOSAN Dr. Künzer GmbH based?
APOSAN Dr. Künzer GmbH is headquartered in Köln, Germany, in the Europe region.
How does APOSAN Dr. Künzer GmbH make money?
Four revenue lines are on record. Compounding Pharmacy - Patient-Individual Medications are the primary driver. The others are medical Supplies and Devices, shipping Pharmacy - Standard Products and care Coordination and Transfer Management Services.
Who are APOSAN Dr. Künzer GmbH's main competitors?
Emerging players on record are EVER Pharma, Hameln Pharma GmbH and Sedana Medical AB. Direct peers are Baxter International, Fresenius Kabi and B. Braun Melsungen AG. CSL Behring is listed as a broad incumbent. Regional players are Healthcare at Home (UK), Shop Apotheke Europe NV and DocMorris (Zur Rose Group).
Does APOSAN Dr. Künzer GmbH have an API?
No public API is recorded for APOSAN Dr. Künzer GmbH.
What industry is APOSAN Dr. Künzer GmbH in?
APOSAN Dr. Künzer GmbH's product category is Compounding Pharmacy / Home Infusion Services. Its primary akta.pro industry code is HLAFALAG, Infusion & Home Infusion Pharmacy Services, with a secondary code of HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile). Its NAICS code is 62161 and its SIC code is 8082.